INCYTE CORP 4

Patrick A. Mayes, EVP & Chief Scientific Officer of Incyte Corp. (INCY), exercised 2,207 stock options at $106.47 and sold 2,207 common shares at $123.99 on August 5, 2026.

On August 5, 2026, Patrick A. Mayes, EVP & Chief Scientific Officer of Incyte Corporation, exercised 2,207 employee stock options at $106.47 per share, acquiring 2,207 shares of common stock, and on the same day sold 2,207 shares at $123.99 per share in a likely cashless or tax-related transaction. The option exercise generated an implied value of approximately $235,000 in shares, while the sale totaled about $274,000, with post-transaction direct ownership reported at 61,441 shares of common stock. The filing notes that his holdings include 59,537 unvested RSUs and that the option award is fully vested and exercisable as of August 5, 2026.

Filing Facts

CIK

879169

Ticker

INCY

Form

4

Source Type

fda

Accession

0002079962-26-000015

Alert Tier

6